These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38150537)

  • 21. Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies.
    Porciatti V; Chou TH
    Cells; 2021 Jun; 10(6):. PubMed ID: 34198840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All roads lead to glaucoma: Induced retinal injury cascades contribute to a common neurodegenerative outcome.
    Alqawlaq S; Flanagan JG; Sivak JM
    Exp Eye Res; 2019 Jun; 183():88-97. PubMed ID: 30447198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
    Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
    J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.
    Cen LP; Ng TK; Liang JJ; Xu C; Zhuang X; Liu YF; Chen SL; Xu Y; Yang Q; Yuan XL; Qin YJ; Chan SO; Chen H; Zhang M; Schally AV; Pang CP
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells.
    Schmitt HM; Schlamp CL; Nickells RW
    Neurosci Lett; 2016 Jun; 625():11-5. PubMed ID: 26733303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current understanding of neuroprotection in glaucoma.
    Wein FB; Levin LA
    Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies.
    Lee S; Van Bergen NJ; Kong GY; Chrysostomou V; Waugh HS; O'Neill EC; Crowston JG; Trounce IA
    Exp Eye Res; 2011 Aug; 93(2):204-12. PubMed ID: 20691180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma.
    Williams PA; Howell GR; Barbay JM; Braine CE; Sousa GL; John SW; Morgan JE
    PLoS One; 2013; 8(8):e72282. PubMed ID: 23977271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV
    Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection in Optic Neuropathy.
    Levin LA
    Asia Pac J Ophthalmol (Phila); 2018; 7(4):246-250. PubMed ID: 30066502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative Stress in Optic Neuropathies.
    Sanz-Morello B; Ahmadi H; Vohra R; Saruhanian S; Freude KK; Hamann S; Kolko M
    Antioxidants (Basel); 2021 Sep; 10(10):. PubMed ID: 34679672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal regeneration after optic nerve crush in mice.
    Masuda S; Tanaka S; Shiraki H; Sotomaru Y; Harada K; Hide I; Kiuchi Y; Sakai N
    Neurobiol Dis; 2022 Oct; 172():105811. PubMed ID: 35809764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulated Necrosis in Glaucoma: Focus on Ferroptosis and Pyroptosis.
    Chen D; Miao S; Chen X; Wang Z; Lin P; Zhang N; Yang N
    Mol Neurobiol; 2024 May; 61(5):2542-2555. PubMed ID: 37910286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
    Shinozaki Y; Kashiwagi K; Namekata K; Takeda A; Ohno N; Robaye B; Harada T; Iwata T; Koizumi S
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optic nerve disease and axon pathophysiology.
    Ghaffarieh A; Levin LA
    Int Rev Neurobiol; 2012; 105():1-17. PubMed ID: 23206593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in retinal ganglion cell imaging.
    Balendra SI; Normando EM; Bloom PA; Cordeiro MF
    Eye (Lond); 2015 Oct; 29(10):1260-9. PubMed ID: 26293138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death.
    Welsbie DS; Yang Z; Ge Y; Mitchell KL; Zhou X; Martin SE; Berlinicke CA; Hackler L; Fuller J; Fu J; Cao LH; Han B; Auld D; Xue T; Hirai S; Germain L; Simard-Bisson C; Blouin R; Nguyen JV; Davis CH; Enke RA; Boye SL; Merbs SL; Marsh-Armstrong N; Hauswirth WW; DiAntonio A; Nickells RW; Inglese J; Hanes J; Yau KW; Quigley HA; Zack DJ
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):4045-50. PubMed ID: 23431148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
    Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
    Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.